News & Insights

February 19, 2026 | Why We Invested

Translating Code When Failure is Not an Option: Why We Invested in
Code Metal

February 17, 2026 | Why We Invested

Why We Invested
in JetZero

January 22, 2026 | Why We Invested

Why We Invested
in Fervo Energy

November 24, 2025 | Why We Invested

B Capital Why We Invested: Solve Therapeutics

Healthcare
October 23, 2025 | News

B Capital Highlights AI-Driven Investment Momentum and Global Thought Leadership at 2025 Annual General Meeting and CEO Summit

Firm News
September 30, 2025 | Why We Invested

Toward Mathematical Superintelligence: Why We Invested in Axiom

Technology
July 31, 2025 | Why We Invested

Why We Invested:
ARTBIO

Healthcare
July 10, 2025 | Insights

Part 2: The Buyer’s Playbook – A Strategic Guide to M&A from the Acquirer’s Perspective

Capital Advisory
April 8, 2025 | Insights

How to Be Bought (vs. Sold): A Strategic Approach to M&A

Capital Advisory
March 13, 2025 | Insights

Climate 3.0: Investing in Scalable, Profitable Climate Solutions

Resilience Tech
January 23, 2025 | News

B Capital Appoints Yan-David Erlich as General Partner

Firm News
January 14, 2025 | Insights

3 Ways Global Venture Capital Can Drive Transformative Change

January 9, 2025 | Why We Invested

Why We Invested:
Eureka Robotics

Asia
December 5, 2024 | Why We Invested

Why We Invested:
Nuvig Therapeutics

Healthcare
November 18, 2024 | News

B Capital Appoints Timur Akazhanov as General Partner

Firm News
November 7, 2024 | Why We Invested

Why We Invested: Evommune

Healthcare